NASDAQ:NAOV NanoVibronix (NAOV) Stock Price, News & Analysis → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free NAOV Stock Alerts $0.77 +0.02 (+2.67%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.76▼$0.7850-Day Range$0.75▼$1.1852-Week Range$0.70▼$4.34Volume7,817 shsAverage Volume21,321 shsMarket Capitalization$2.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get NanoVibronix alerts: Email Address Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. About NanoVibronix Stock (NASDAQ:NAOV)NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.Read More NAOV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NAOV Stock News HeadlinesApril 20, 2024 | americanbankingnews.comNanoVibronix (NASDAQ:NAOV) Share Price Passes Below Fifty Day Moving Average of $0.95April 10, 2024 | investorplace.comNAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023April 26, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… April 9, 2024 | businesswire.comNanoVibronix Issues Letter to StockholdersMarch 28, 2024 | finance.yahoo.comNanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShieldFebruary 23, 2024 | benzinga.comMagnolia Oil & Gas Stock (NYSE:MGY), Quotes and News SummaryFebruary 2, 2024 | uk.finance.yahoo.comNanoVibronix, Inc. (NAOV)January 7, 2024 | morningstar.comNanoVibronix Inc NAOVApril 26, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… December 6, 2023 | finance.yahoo.comNanoVibronix Featured in Your Bladder Health MagazineDecember 4, 2023 | finance.yahoo.comNanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution OpportunityNovember 28, 2023 | markets.businessinsider.comNanoVibronix Stock Slips 10%, Sings Research Agreement With Regents Of The University Of MichiganNovember 28, 2023 | finance.yahoo.comNanoVibronix Announces Agreement for Clinical Study of UroShield at the University of MichiganNovember 7, 2023 | finance.yahoo.comNanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1September 27, 2023 | finanznachrichten.deNanoVibronix, Inc.: NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug TariffSeptember 27, 2023 | finance.yahoo.comNanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffSeptember 6, 2023 | finance.yahoo.comNanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual MeetingAugust 31, 2023 | seekingalpha.comAMC, MMLP and ARAV among mid-day moversAugust 30, 2023 | msn.comNanoVibronix to raise $5M through private placementAugust 30, 2023 | finance.yahoo.comWhy Is NanoVibronix Stock Trading Higher Today?August 30, 2023 | finance.yahoo.comNanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq RulesAugust 30, 2023 | investorplace.comWhy Is NanoVibronix (NAOV) Up 153% Today?August 30, 2023 | finance.yahoo.comNanoVibronix Cites Positive Results from Independent Testing of UroShieldAugust 29, 2023 | finance.yahoo.comNanoVibronix Responds to CMS’ Determination for PainShieldAugust 28, 2023 | finance.yahoo.comNanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffAugust 23, 2023 | markets.businessinsider.comNanoVibronix Extends Distribution Deal With UPPI For PainShield, PainShield PlusAugust 23, 2023 | finance.yahoo.comNanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield PlusSee More Headlines Receive NAOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NanoVibronix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/08/2024Today4/26/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:NAOV CUSIPN/A CIK1326706 Webwww.nanovibronix.com Phone(914) 233-3004Fax914-376-6111Employees9Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,710,000.00 Net Margins-162.55% Pretax Margin-161.28% Return on Equity-123.23% Return on Assets-65.46% Debt Debt-to-Equity RatioN/A Current Ratio2.64 Quick Ratio1.53 Sales & Book Value Annual Sales$2.28 million Price / Sales0.94 Cash FlowN/A Price / Cash FlowN/A Book Value$1.95 per share Price / Book0.39Miscellaneous Outstanding Shares2,780,000Free Float2,684,000Market Cap$2.14 million OptionableNot Optionable Beta1.25 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Brian M. Murphy (Age 67)CEO & Director Comp: $342.5kMr. Stephen R. Brown CPA (Age 68)Chief Financial Officer Comp: $276.5kDr. Harold Jacob M.D. (Age 70)Chief Medical Officer & Director Mr. Amir RippelVice President of MarketingMs. Lindsey HarrisonVice President of SalesKey CompetitorsBone BiologicsNASDAQ:BBLGSientraNASDAQ:SIENQPredictive OncologyNASDAQ:POAIHeart Test LaboratoriesNASDAQ:HSCSAclarionNASDAQ:ACONView All Competitors NAOV Stock Analysis - Frequently Asked Questions How have NAOV shares performed in 2024? NanoVibronix's stock was trading at $1.15 at the beginning of 2024. Since then, NAOV stock has decreased by 33.2% and is now trading at $0.7680. View the best growth stocks for 2024 here. Are investors shorting NanoVibronix? NanoVibronix saw a drop in short interest in March. As of March 31st, there was short interest totaling 2,700 shares, a drop of 63.0% from the March 15th total of 7,300 shares. Based on an average trading volume of 97,400 shares, the short-interest ratio is presently 0.0 days. Approximately 0.1% of the shares of the stock are sold short. View NanoVibronix's Short Interest. When is NanoVibronix's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our NAOV earnings forecast. How were NanoVibronix's earnings last quarter? NanoVibronix, Inc. (NASDAQ:NAOV) announced its quarterly earnings data on Monday, April, 8th. The company reported ($0.39) EPS for the quarter. The company earned $1.18 million during the quarter. NanoVibronix had a negative net margin of 162.55% and a negative trailing twelve-month return on equity of 123.23%. When did NanoVibronix's stock split? Shares of NanoVibronix split on Thursday, October 13th 2022. The 2-1 split was announced on Thursday, October 13th 2022. The newly minted shares were distributed to shareholders after the market closes on Thursday, October 13th 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What other stocks do shareholders of NanoVibronix own? Based on aggregate information from My MarketBeat watchlists, some companies that other NanoVibronix investors own include T2 Biosystems (TTOO), ADMA Biologics (ADMA), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP), BIO-key International (BKYI), Digital Ally (DGLY), iBio (IBIO) and How do I buy shares of NanoVibronix? Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NAOV) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoVibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
